Search Results 221-230 of 30730 for Ovarian
The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.
... Ovarian Cancer Liquid Biopsy among women with ovarian adnexal mass for which a surgery is planned. Participation eligibility. Participant eligibility ...
Ovarian cancer vaccines are a type of immunotherapy, which is treatment that harnesses the body's germ-fighting immune system to attack cancer cells.
... ovarian cancer at Mayo Clinic Rochester and to determine barriers to genetics counseling and testing from a patient perspective. Participation eligibility.
... ovarian cancer cells with deleterious BRCA1 or BRCA2 mutations. Building on these observations, Dr. Kaufmann's lab has been trying to understand the unique ...
... ovarian cancer. Significance to patient care. Despite the well-documented importance of immune infiltration in ovarian tumors to patient outcome, responses ...
If you've had a hysterectomy, your risk of developing ovarian cancer or primary peritoneal cancer, a type of cancer that acts like ovarian cancer, ...
What researchers learn from this study could possibly be used in the future to prevent or delay recurrence of breast or ovarian cancers. Participation ...
Giving carboplatin and gemcitabine with or without ATR kinase inhibitor VX-970 may work better in treating ovarian, primary peritoneal, or fallopian tube cancer ...
A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.